{"title": "Un ensayo cl\u00ednico inicial destaca las vacunas contra el c\u00e1ncer como posible tratamiento asequible, seguro y eficaz contra el c\u00e1ncer de mama", "author": "R Lex; Traducido al espa\u00f1ol por \u00c1ngela Mar\u00eda Carvajal y revisado por Adriana Nodal-Tarafa", "url": "https://www.fredhutch.org/en/news/spotlight/2023/07/ccsg-disis-jamaoncology-spanish.html", "hostname": "fredhutch.org", "description": "La vacuna de ADN para el c\u00e1ncer de mama mejora la supervivencia de las pacientes con c\u00e1ncer de mama HER2 positivo en estadio tard\u00edo en un ensayo cl\u00ednico no aleatorizado de fase I.", "sitename": "Fred Hutch", "date": "2023-07-17", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "This story was published in\n[English](https://www.fredhutch.org/en/news/spotlight/2023/07/ccsg-disis-jamaoncology.html) on July 17th, 2023.\nTanto las personas que padecen c\u00e1ncer como los equipos de investigaci\u00f3n sue\u00f1an con el d\u00eda en que puedan desarrollarse tratamientos que no s\u00f3lo sean eficaces, sino tambi\u00e9n asequibles y con pocos efectos secundarios, ya que estos lujos no han formado parte de las terapias eficaces contra el c\u00e1ncer del pasado. Un trabajo reciente del\n[Cancer Vaccine Institute](https://www.uwcvi.org/) (CVI) de la Universidad de Washington (UW), que forma parte del [Cancer Consortium Breast & Ovary Cancers Program](https://www.cancerconsortium.org/about/research-programs.html), demuestra que ese d\u00eda puede estar m\u00e1s cerca de lo que parece. En su estudio reci\u00e9n publicado en [JAMA Oncology,](https://jamanetwork.com/journals/jamaoncology/article-abstract/2797975) el equipo del CVI mostr\u00f3 resultados prometedores de un ensayo cl\u00ednico no aleatorizado de fase I con una vacuna contra el c\u00e1ncer de mama en pacientes con c\u00e1ncer de mama HER2-positivo en estadio avanzado. Tras un periodo de seguimiento de 10 a\u00f1os, esta vacuna de ADN demostr\u00f3 ser segura y eficaz, y la mayor\u00eda de las mujeres participantes siguen sin tener c\u00e1ncer. Aunque se limitan a un n\u00famero reducido de pacientes, los resultados de este ensayo son muy prometedores.\nEl c\u00e1ncer de mama es s\u00f3lo uno de los seis c\u00e1nceres de tumores s\u00f3lidos que el Cancer Vaccine Institute de la UW tiene como objetivo para el desarrollo de vacunas, ya que tambi\u00e9n dirige sus esfuerzos a tratar los c\u00e1nceres de ovario, colon, pulm\u00f3n, vejiga y pr\u00f3stata.\n[La Dra. Mary (Nora) Disis](https://www.uwcvi.org/team/mary-%28nora%29-disis%2C-md), directora del CVI, fue una de las investigadoras pioneras en identificar el HER2 como ant\u00edgeno tumoral, y el desarrollo de una vacuna contra el c\u00e1ncer de mama fue uno de los objetivos iniciales del instituto. Adem\u00e1s de su trabajo en el CVI, Disis es Decana Asociada de las Ciencias Traslacionales de la Facultad de Medicina de la [UW y profesora asociada de la UW y Fred Hutch](https://www.fredhutch.org/en/faculty-lab-directory/disis-nora-mary.html). La misi\u00f3n del CVI \"es utilizar vacunas contra el c\u00e1ncer y otras terapias que inciten al sistema inmunitario para acabar con el c\u00e1ncer\", explic\u00f3 la directora ejecutiva del CVI, la [Dra. Kiran Dhillon](https://www.uwcvi.org/team/kiran-dhillon%2C-phd). Dhillon tambi\u00e9n describi\u00f3 la estructura simplificada \u00fanica del CVI, que consta de cinco investigadores principales e instalaciones centrales donde \"todo lo que hacemos est\u00e1 dise\u00f1ado para llegar a la cl\u00ednica\". \"Logramos interrumpir el modelo tradicional de laboratorio al conectar el descubrimiento temprano, la investigaci\u00f3n traslacional y el trabajo de ensayo cl\u00ednico bajo un mismo techo\", a\u00f1adi\u00f3.\nAntes de que pudieran desarrollar la prometedora vacuna de ADN contra el HER2 que se destaca en este estudio, tuvieron que probar y equivocarse para averiguar c\u00f3mo fabricar una vacuna eficaz contra el c\u00e1ncer. Dhillon indic\u00f3 que \"el verdadero avance se produjo hace unos ocho a\u00f1os, cuando llegamos a comprender c\u00f3mo la misma prote\u00edna, o ant\u00edgeno, pod\u00eda tener diferentes respuestas del sistema inmunitario\". Por ejemplo, una parte de la prote\u00edna puede provocar una fuerte respuesta destructiva de los tejidos que acabe con las c\u00e9lulas cancerosas, mientras que otra parte puede promover una inhibici\u00f3n inmunitaria desfavorable. \"Ya comprendimos c\u00f3mo funciona ese sistema y ahora tenemos el martillo para combatir el c\u00e1ncer.\" exclam\u00f3 Dhillon emocionada. El equipo de investigadores del CVI es consciente de que cada tipo de c\u00e1ncer plantea retos terap\u00e9uticos \u00fanicos, por eso dise\u00f1aron vacunas que act\u00faan en tres fases del tratamiento del c\u00e1ncer: prevenci\u00f3n, tratamiento y recurrencia. Aunque estas vacunas no est\u00e1n dise\u00f1adas para funcionar como la vacuna anual contra la gripe, su objetivo es ayudar a prevenir el c\u00e1ncer en pacientes de alto riesgo (prevenci\u00f3n o intercepci\u00f3n), funcionar en combinaci\u00f3n con las quimioterapias actuales para aumentar su eficacia (tratamiento) o ayudar a evitar que los c\u00e1nceres reaparezcan despu\u00e9s de haber sido tratados inicialmente (recurrencia). Por lo general, todas las vacunas contra el c\u00e1ncer funcionan al \"entrenar al sistema inmunitario para que reconozca como peligrosas a las c\u00e9lulas cancerosas que expresan prote\u00ednas espec\u00edficas, activando las alarmas y la se\u00f1alizaci\u00f3n para atacar a dichas c\u00e9lulas\", explic\u00f3 Dhillon. Estas c\u00e9lulas T entrenadas recorren todo el cuerpo, incluso el cerebro, el cual es un lugar habitual y dif\u00edcil de atacar de la met\u00e1stasis del c\u00e1ncer de mama, ya que muchos f\u00e1rmacos no pueden atravesar la barrera hematoencef\u00e1lica. As\u00ed, este enfoque puede superar uno de los retos actuales de las pautas terap\u00e9uticas basadas en f\u00e1rmacos.\nPara centrarse en el tratamiento de este c\u00e1ncer de mama agresivo, con el martillo en mano, Disis y el equipo de investigaci\u00f3n del CVI desarrollaron una vacuna de ADN que codifica el dominio intracelular de la prote\u00edna HER2 (entrenando as\u00ed al sistema inmunitario para atacar a las c\u00e9lulas cancerosas que expresan HER2) para tratar a 66 pacientes con c\u00e1ncer de mama HER2-positivo en estadio III o IV. Antes de la vacunaci\u00f3n, todas las personas se hab\u00edan curado eficazmente del c\u00e1ncer mediante el tratamiento con f\u00e1rmacos quimioterap\u00e9uticos como Trastuzumab. Aunque las pacientes estaban t\u00e9cnicamente sin c\u00e1ncer en esta fase previa a la vacuna, los c\u00e1nceres de mama HER2-positivos son agresivos, con una alta probabilidad de recurrencia y met\u00e1stasis. Pero \u00a1aqu\u00ed es donde entra en juego la vacuna! Las pacientes recibieron una de las tres dosis mensuales de esta vacuna de ADN durante un periodo de 3 meses. Las vacunas resultaron ser muy seguras, con reacciones adversas extremadamente leves, similares a los dolores y escalofr\u00edos que se pueden experimentar con las vacunas de COVID-19 o contra la gripe- un paseo por el parque en comparaci\u00f3n con los tratamientos actuales, m\u00e1s t\u00f3xicos, contra el c\u00e1ncer. Luego, Disis y sus colegas evaluaron la respuesta inmunitaria de las pacientes a las vacunas al analizar muestras de sangre tomadas en distintos momentos despu\u00e9s la vacunaci\u00f3n. Con la colaboraci\u00f3n de la\n[Dra. Katherine Guthrie](https://www.fredhutch.org/en/faculty-lab-directory/guthrie-katherine.html), profesora del Programa de Prevenci\u00f3n del C\u00e1ncer de Fred Hutch, para analizar los datos de las pacientes, los investigadores observaron una fuerte respuesta inmunitaria a todas las dosis de vacunas administradas. Sin embargo, la dosis intermedia pareci\u00f3 ser la m\u00e1s eficaz, con una respuesta inmunitaria que se mantuvo a lo largo del tiempo. Esta respuesta inmunitaria iba acompa\u00f1ada de un aumento de las c\u00e9lulas T de memoria central, que son importantes para la inmunidad a largo plazo. Adem\u00e1s, con esta dosis, la supervivencia media tras un periodo de 10 a\u00f1os para estas pacientes con c\u00e1ncer de mama en estadio avanzado fue de ~85% entre las pacientes en estadio III y IV; y cabe destacar que todas las mujeres en estadio III siguen vivas en la actualidad. En comparaci\u00f3n, la tasa de supervivencia de las pacientes con c\u00e1ncer de mama en estadio III/IV que reciben las quimioterapias actualmente disponibles es de s\u00f3lo el 50% a los 4.5 a\u00f1os despu\u00e9s del tratamiento. El notable aumento de las tasas de supervivencia en este ensayo cl\u00ednico de fase I recalca la eficacia de las vacunas para este c\u00e1ncer de mama agresivo y da esperanzas de que los tratamientos contra el c\u00e1ncer basados en vacunas eficaces, asequibles y accesibles puedan ser una realidad en el futuro para otros tipos de c\u00e1ncer. En asociaci\u00f3n con [Aston Sci.](http://astonsci.com/), la vacuna desarrollada en el CVI se utilizar\u00e1 en ensayos cl\u00ednicos aleatorizados de fase II que se ampliar\u00e1n para incluir a pacientes con otros tipos de c\u00e1ncer de mama dif\u00edciles de tratar y que podr\u00edan beneficiarse de un enfoque terap\u00e9utico dirigido a HER2. Es importante se\u00f1alar que la aprobaci\u00f3n final por parte de la FDA (Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos) para su uso fuera de los ensayos cl\u00ednicos exigir\u00e1 ensayos aleatorios de fase III a\u00fan m\u00e1s amplios, que pongan a prueba de forma rigurosa su eficacia.\nComo terapia contra el c\u00e1ncer para su distribuci\u00f3n comercial, las vacunas se perfilan como un nuevo tratamiento prometedor que podr\u00eda estar ampliamente disponible, ser asequible, seguro y eficaz, y cuyas reacciones adversas no ser\u00edan peores que las de una inyecci\u00f3n de la vacuna de COVID-19. Adem\u00e1s de los equipos de investigaci\u00f3n del CVI, estos emocionantes avances no habr\u00edan sido posibles sin el trabajo de varios actores clave, como el Programa de C\u00e1ncer de la Mujer del Consorcio UW/Fred Hutch/Seattle Children's, que ayud\u00f3 a inscribir pacientes para los ensayos cl\u00ednicos, y las instalaciones GMP de Fred Hutch, que fabricaron las vacunas para este trabajo. Mientras que a Dhillon la entusiasman los resultados cient\u00edficos de este estudio, tambi\u00e9n resalt\u00f3 la importancia de las pacientes para lograrlos. La doctora hizo \u00e9nfasis en el agradecimiento que CVI tiene por sus pacientes, \"ya que nada de lo que hacemos ser\u00eda posible sin su participaci\u00f3n. Cada paciente es el eje central de todo lo que hacemos\". El equipo del CVI pone en pr\u00e1ctica este valor al coordinar reuniones de pacientes participantes y eventos educativos para informar a la gente sobre las vacunas contra el c\u00e1ncer y los ensayos cl\u00ednicos, con especial atenci\u00f3n a la celebraci\u00f3n de estos eventos para comunidades diversas que no est\u00e1n bien representadas en los ensayos cl\u00ednicos. Para destacar la fuerte relaci\u00f3n que CVI establece con sus pacientes, Dhillon mencion\u00f3 que m\u00e1s de 10 a\u00f1os despu\u00e9s del ensayo cl\u00ednico de la vacuna HER2, una paciente la llam\u00f3 recientemente para decirle: \"\u00a1Sigo aqu\u00ed!\" Esta simple llamada telef\u00f3nica hubiera sido imposible sin esta vacuna contra el c\u00e1ncer de mama.\nQuienes tengan inter\u00e9s en conocer m\u00e1s ensayos cl\u00ednicos pueden consultar los recursos que aparecen a continuaci\u00f3n.\n-Para obtener m\u00e1s informaci\u00f3n sobre los ensayos cl\u00ednicos actuales de CVI de UW y la informaci\u00f3n de contacto de estos estudios para quienes les interese inscribirse, haga clic\n[aqu\u00ed.](https://www.uwcvi.org/clinical-trial-opportunities)\n-Para saber m\u00e1s sobre c\u00f3mo participar en ensayos cl\u00ednicos y los riesgos y beneficios que conllevan, haga clic\n[aqu\u00ed.](https://www.uwcvi.org/immunology-101-faq)\nEste trabajo fue financiado por los Institutos Nacionales de la Salud de los Estados Unidos, el Instituto Nacional del C\u00e1ncer, el Centro Nacional para el Avance de las Ciencias Traslacionales, la C\u00e1tedra Patrocinada Helen B. Slonaker para la investigaci\u00f3n del c\u00e1ncer y la American Cancer Society.\nLos miembros del Consorcio del C\u00e1ncer UW/Fred Hutch/Seattle Children's, Mary (Nora) Disis, Katherine Guthrie y Andrew Coveler contribuyeron a este trabajo.\n[Disis MLN, Guthrie KA, Liu Y, Coveler AL, Higgins DM, Childs JS, Dang Y, Salazar LG.](https://pubmed.ncbi.nlm.nih.gov/36326756/) 2023. Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients with Advanced-Stage ERBB2-Positive Breast Cancer: A Phase 1 Nonrandomized Clinical Trial. JAMA Oncol. 9(1):71-78.\nEste art\u00edculo fue traducido de la versi\u00f3n original en ingl\u00e9s al espa\u00f1ol por \u00c1ngela Mar\u00eda Carvajal con la revisi\u00f3n de Adriana Nodal-Tarafa en coordinaci\u00f3n con las escritoras actuales Joselyn Landazuri y Annabel Olson.", "language": null, "image": "https://www.fredhutch.org/content/dam/www/science-spotlight/2023/07/CVI_patients.png", "pagetype": "article", "links": ["/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/patient-care/for-physicians.html", "/en/about/careers.html", "/en/about/fred-hutch-locations.html", "/en/about/contact-us.html", "/en.html", null, "/en/patient-care.html", "/en/patient-care/patient-services.html", "/en/patient-care/patient-services/insurance-and-billing.html", "/en/patient-care/patient-services/medical-record-request.html", "/en/patient-care/patient-services/pharmacy.html", "/en/patient-care/patient-services/housing.html", "/en/patient-care/patient-services/amenities.html", "/en/patient-care/patient-services/interpreter-services.html", "/en/patient-care/patient-services/telehealth.html", "/en/patient-care/for-caregivers.html", "/en/patient-care/for-caregivers/resources.html", "/en/patient-care/services.html", "/en/patient-care/services/cancer-rehabilitation.html", "/en/patient-care/services/child-life.html", "/en/patient-care/services/integrative-medicine.html", "/en/patient-care/services/nutrition.html", "/en/patient-care/services/oncoreproduction-clinic.html", "/en/patient-care/services/pain-clinic.html", "/en/patient-care/services/palliative-care.html", "/en/patient-care/services/patient-navigators.html", "/en/patient-care/services/physical-therapy.html", "/en/patient-care/services/psychiatry.html", "/en/patient-care/services/sexual-health.html", "/en/patient-care/services/social-work.html", "/en/patient-care/services/spiritual-health.html", "/en/patient-care/services/support-groups.html", "/en/patient-care/services/survivorship.html", "/en/patient-care/treatments.html", "/en/patient-care/treatments/blood-marrow-transplant.html", "/en/patient-care/treatments/immunotherapy.html", "/en/patient-care/treatments/medical-oncology.html", "/en/patient-care/treatments/radiation-oncology.html", "/en/patient-care/treatments/surgical-oncology.html", "/en/patient-care/treatments/proton-therapy.html", "/en/patient-care/treatments/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy.html", "/en/patient-care/prevention.html", "/en/patient-care/prevention/breast-cancer-screening.html", "/en/patient-care/prevention/colorectal-cancer-early-detection.html", "/en/patient-care/prevention/genetic-counseling-clinical-genetics.html", "/en/patient-care/prevention/lung-cancer-early-detection.html", "/en/patient-care/prevention/prostate-cancer-early-detection.html", "/en/patient-care/prevention/womens-wellness.html", "/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/about/fred-hutch-locations.html", "/en/patient-care/covid19.html", "/en/education-training/patient-education.html", "/en/about/contact-us/transportation.html", "/en/about/contact-us.html", null, "/en/diseases.html", "/en/diseases/acute-lymphoblastic-leukemia.html", "/en/diseases/acute-myeloid-leukemia.html", "/en/diseases/adrenal-cancer.html", "/en/diseases/amyloidosis.html", "/en/diseases/anal-cancer.html", "/en/diseases/aplastic-anemia.html", "/en/diseases/autoimmune-diseases.html", "/en/diseases/bladder-cancer.html", "/en/diseases/blood-disorders.html", "/en/diseases/brain-and-spinal-cord-cancers.html", "/en/diseases/breast-cancer.html", "/en/diseases/cervical-cancer.html", "/en/diseases/chronic-lymphocytic-leukemia.html", "/en/diseases/chronic-myeloid-leukemia.html", "/en/diseases/colon-cancer.html", "/en/diseases/cutaneous-lymphoma.html", "/en/diseases/endocrine-tumors.html", "/en/diseases/endometrial-cancer.html", "/en/diseases/esophageal-cancer.html", "/en/diseases/gastrointestinal-cancer.html", "/en/diseases/gynecologic-cancer.html", "/en/diseases/head-and-neck-cancers.html", "/en/diseases/hodgkin-lymphoma.html", "/en/diseases/kidney-cancer.html", "/en/diseases/leukemia.html", "/en/diseases/liver-tumors-cancer.html", "/en/diseases/lung-cancer.html", "/en/diseases/lymphedema.html", "/en/diseases/melanoma.html", "/en/diseases/merkel-cell-carcinoma.html", "/en/diseases/mesothelioma.html", "/en/diseases/multiple-myeloma.html", "/en/diseases/myelodysplastic-syndrome.html", "/en/diseases/myeloproliferative-neoplasms.html", "/en/diseases/neuroendocrine-tumors.html", "/en/diseases/non-hodgkin-lymphoma.html", "/en/diseases/oral-cancer.html", "/en/diseases/ovarian-cancer.html", "/en/diseases/pancreatic-cancer.html", "/en/diseases/parathyroid-cancer.html", "/en/diseases/prostate-cancer.html", "/en/diseases/rectal-cancer.html", "/en/diseases/salivary-gland-cancer.html", "/en/diseases/sarcoma.html", "/en/diseases/sickle-cell-disease.html", "/en/diseases/skin-cancer.html", "/en/diseases/stomach-cancer.html", "/en/diseases/testicular-cancer.html", "/en/diseases/thyroid-cancer.html", "/en/diseases/uterine-sarcoma.html", "/en/diseases/vulvar-cancer.html", "/en/diseases/waldenstrom-macroglobulinemia.html", null, "/en/research.html", "/en/research/research-areas.html", "/en/research/research-areas/behavioral-research.html", "/en/research/research-areas/biostatistics.html", "/en/research/research-areas/cell-gene-therapy.html", "/en/research/research-areas/cell-biology.html", "/en/research/research-areas/data-science.html", "/en/research/research-areas/diagnostics-biomarkers.html", "/en/research/research-areas/disease-prevention.html", "/en/research/research-areas/epidemiology.html", "/en/research/research-areas/gene-regulation-expression.html", "/en/research/research-areas/genetics-and-genomics.html", "/en/research/research-areas/global-health.html", "/en/research/research-areas/health-economics.html", "/en/research/research-areas/hematopoietic-transplantation.html", "/en/research/research-areas/immunotherapy.html", "/en/research/research-areas/infectious-diseases.html", "/en/research/research-areas/microbiome.html", "/en/research/research-areas/survivorship.html", "/en/research/research-areas/vaccine-development.html", "/en/research/research-areas/virology.html", "/en/research/diseases.html", "/en/research/diseases/autoimmune-diseases.html", "/en/research/diseases/cancers.html", "/en/research/diseases/coronavirus.html", "/en/research/diseases/genetic-disorders.html", "/en/research/diseases/herpes.html", "/en/research/diseases/hiv-aids.html", "/en/research/divisions.html", "/en/research/divisions/basic-sciences-division.html", "/en/research/divisions/clinical-research-division.html", "/en/research/divisions/human-biology-division.html", "/en/research/divisions/public-health-sciences-division.html", "/en/research/divisions/vaccine-infectious-disease-division.html", "/en/research/clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials/health-insurance.html", "/en/research/clinical-trials/guide-clinical-trials/deciding-to-participate.html", "/en/research/covid-19-clinical-research-center.html", "/en/research/patient-treatment-support/long-term-follow-up.html", "/en/research/patient-treatment-support/survivorship-program.html", "https://www.cookforyourlife.org/", "/en/faculty-lab-directory.html", "/en/education-training.html", "/en/research/institutes-networks-ircs.html", "/en/research/institutes-networks-ircs/ocoe.html", "/en/projects.html", "/en/research/scientific-publications.html", "/en/research/shared-resources.html", "/en/investors.html", null, "/en/education-training.html", "/en/education-training/patient-education.html", "/en/education-training/patient-education/resource-center.html", "/en/education-training/patient-education/courses.html", "/en/education-training/patient-education/videos.html", "/en/education-training/health-care-professionals.html", "/en/education-training/health-care-professionals/provider-professional-development.html", "/en/education-training/health-care-professionals/nursing-professional-development.html", "/en/education-training/teachers-students.html", "/en/education-training/teachers-students/science-education-partnership.html", "/en/education-training/teachers-students/high-school-undergraduate-students.html", "/en/education-training/open-internships.html", "/en/education-training/faculty-professional-development-training-and-mentoring.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/graduate-program.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/postdoctoral-fellows-programs.html", null, "/en/about.html", "/en/about/about-the-hutch.html", "/en/about/about-the-hutch/patient-care-at-fred-hutch.html", "/en/about/about-the-hutch/accountability-impact.html", "/en/about/about-the-hutch/diversity-equity-inclusion.html", "/en/about/about-the-hutch/health-equity.html", "/en/about/about-the-hutch/history.html", "/en/about/about-the-hutch/honors-awards.html", "/en/about/about-the-hutch/institutional-partners-collaborations.html", "/en/about/about-the-hutch/leadership.html", "/en/about/about-the-hutch/mission-values.html", "/en/about/contact-us.html", "/en/about/contact-us/campus-map.html", "/en/about/contact-us/virtual-visit.html", "/en/about/contact-us/transportation.html", "/en/about/fred-hutch-locations.html", "/en/about/careers.html", "/en/events.html", "/en/about/for-media.html", "/en/news.html", null, "/en/ways-to-give.html", "/en/ways-to-give/give-now.html", "/en/ways-to-give/honor-a-loved-one.html", "/en/ways-to-give/give-through-your-will.html", "/en/ways-to-give/give-through-your-donor-advised-fund.html", "/en/ways-to-give/donate-cryptocurrency.html", "/en/ways-to-give/give-through-your-foundation.html", "/en/ways-to-give/make-a-corporate-gift.html", "/en/ways-to-give/create-an-endowment.html", "/en/ways-to-give/fundraise-for-fred-hutch.html", "https://www.obliteride.org", "/en/ways-to-give/fundraise-for-fred-hutch/create-your-own.html", "/en/ways-to-give/fundraise-for-fred-hutch/fundraiser-login.html", "/en/ways-to-give/philanthropy-events.html", "/en/ways-to-give/support-our-science.html", "/en/ways-to-give/support-our-science/greatest-need.html", "/en/ways-to-give/support-our-science/cancer-research.html", "/en/ways-to-give/support-our-science/data-science.html", "/en/ways-to-give/support-our-science/diversity-and-health-equity.html", "/en/ways-to-give/support-our-science/immunotherapy.html", "/en/ways-to-give/support-our-science/patient-support-services.html", "/en/ways-to-give/support-our-science/precision-oncology.html", "/en/ways-to-give/support-our-science/viruses-vaccines-infectious-diseases.html", "/en/ways-to-give/gift-clubs.html", "/en/ways-to-give/other-ways-to-give.html", "/en/ways-to-give/other-ways-to-give/give-monthly.html", "/en/ways-to-give/other-ways-to-give/donate-stock-bonds-mutual-funds.html", "/en/ways-to-give/other-ways-to-give/give-at-work.html", "/en/ways-to-give/other-ways-to-give/donate-vehicle-or-real-estate.html", "/en/ways-to-give/contact-us.html", "/en/util/redirect_stubs/donate.html", "/en/utility/search.html", "#0", "/en/patient-care.html", "/en/patient-care/patient-services.html", "/en/patient-care/patient-services.html", "/en/patient-care/patient-services/insurance-and-billing.html", "/en/patient-care/patient-services/medical-record-request.html", "/en/patient-care/patient-services/pharmacy.html", "/en/patient-care/patient-services/housing.html", "/en/patient-care/patient-services/amenities.html", "/en/patient-care/patient-services/interpreter-services.html", "/en/patient-care/patient-services/telehealth.html", "/en/patient-care/for-caregivers.html", "/en/patient-care/for-caregivers.html", "/en/patient-care/for-caregivers/resources.html", "/en/patient-care/services.html", "/en/patient-care/services.html", "/en/patient-care/services/cancer-rehabilitation.html", "/en/patient-care/services/child-life.html", "/en/patient-care/services/integrative-medicine.html", "/en/patient-care/services/nutrition.html", "/en/patient-care/services/oncoreproduction-clinic.html", "/en/patient-care/services/pain-clinic.html", "/en/patient-care/services/palliative-care.html", "/en/patient-care/services/patient-navigators.html", "/en/patient-care/services/physical-therapy.html", "/en/patient-care/services/psychiatry.html", "/en/patient-care/services/sexual-health.html", "/en/patient-care/services/social-work.html", "/en/patient-care/services/spiritual-health.html", "/en/patient-care/services/support-groups.html", "/en/patient-care/services/survivorship.html", "/en/patient-care/treatments.html", "/en/patient-care/treatments.html", "/en/patient-care/treatments/blood-marrow-transplant.html", "/en/patient-care/treatments/immunotherapy.html", "/en/patient-care/treatments/medical-oncology.html", "/en/patient-care/treatments/radiation-oncology.html", "/en/patient-care/treatments/surgical-oncology.html", "/en/patient-care/treatments/proton-therapy.html", "/en/patient-care/treatments/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy.html", "/en/patient-care/prevention.html", "/en/patient-care/prevention.html", "/en/patient-care/prevention/breast-cancer-screening.html", "/en/patient-care/prevention/colorectal-cancer-early-detection.html", "/en/patient-care/prevention/genetic-counseling-clinical-genetics.html", "/en/patient-care/prevention/lung-cancer-early-detection.html", "/en/patient-care/prevention/prostate-cancer-early-detection.html", "/en/patient-care/prevention/womens-wellness.html", "/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/about/fred-hutch-locations.html", "/en/patient-care/covid19.html", "/en/education-training/patient-education.html", "/en/about/contact-us/transportation.html", "/en/about/contact-us.html", "#0", "/en/diseases.html", "#0", "/en/research.html", "/en/research/research-areas.html", "/en/research/research-areas.html", "/en/research/research-areas/behavioral-research.html", "/en/research/research-areas/biostatistics.html", "/en/research/research-areas/cell-gene-therapy.html", "/en/research/research-areas/cell-biology.html", "/en/research/research-areas/data-science.html", "/en/research/research-areas/diagnostics-biomarkers.html", "/en/research/research-areas/disease-prevention.html", "/en/research/research-areas/epidemiology.html", "/en/research/research-areas/gene-regulation-expression.html", "/en/research/research-areas/genetics-and-genomics.html", "/en/research/research-areas/global-health.html", "/en/research/research-areas/health-economics.html", "/en/research/research-areas/hematopoietic-transplantation.html", "/en/research/research-areas/immunotherapy.html", "/en/research/research-areas/infectious-diseases.html", "/en/research/research-areas/microbiome.html", "/en/research/research-areas/survivorship.html", "/en/research/research-areas/vaccine-development.html", "/en/research/research-areas/virology.html", null, "/en/research/diseases.html", "/en/research/diseases.html", "/en/research/diseases/autoimmune-diseases.html", "/en/research/diseases/cancers.html", "/en/research/diseases/coronavirus.html", "/en/research/diseases/genetic-disorders.html", "/en/research/diseases/herpes.html", "/en/research/diseases/hiv-aids.html", "/en/research/divisions.html", "/en/research/divisions.html", "/en/research/divisions/basic-sciences-division.html", "/en/research/divisions/clinical-research-division.html", "/en/research/divisions/human-biology-division.html", "/en/research/divisions/public-health-sciences-division.html", "/en/research/divisions/vaccine-infectious-disease-division.html", "/en/research/clinical-trials.html", "/en/research/clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials.html", "/en/research/clinical-trials/guide-clinical-trials/health-insurance.html", "/en/research/clinical-trials/guide-clinical-trials/deciding-to-participate.html", "/en/research/covid-19-clinical-research-center.html", "/en/research/patient-treatment-support/long-term-follow-up.html", "/en/research/patient-treatment-support/survivorship-program.html", "https://www.cookforyourlife.org/", "/en/faculty-lab-directory.html", "/en/education-training.html", "/en/research/institutes-networks-ircs.html", "/en/research/institutes-networks-ircs.html", "/en/research/institutes-networks-ircs/ocoe.html", "/en/projects.html", "/en/research/scientific-publications.html", "/en/research/shared-resources.html", "/en/investors.html", "#0", "/en/education-training.html", "/en/education-training/patient-education.html", "/en/education-training/patient-education.html", "/en/education-training/patient-education/resource-center.html", "/en/education-training/patient-education/courses.html", "/en/education-training/patient-education/videos.html", "/en/education-training/health-care-professionals.html", "/en/education-training/health-care-professionals.html", "/en/education-training/health-care-professionals/provider-professional-development.html", "/en/education-training/health-care-professionals/nursing-professional-development.html", "/en/education-training/teachers-students.html", "/en/education-training/teachers-students.html", "/en/education-training/teachers-students/science-education-partnership.html", "/en/education-training/teachers-students/high-school-undergraduate-students.html", "/en/education-training/open-internships.html", "/en/education-training/faculty-professional-development-training-and-mentoring.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/graduate-program.html", "/en/education-training/post-bac-graduate-post-doc-medical-fellows/postdoctoral-fellows-programs.html", "#0", null, "/en/about.html", "/en/about/about-the-hutch.html", "/en/about/about-the-hutch.html", "/en/about/about-the-hutch/patient-care-at-fred-hutch.html", "/en/about/about-the-hutch/accountability-impact.html", "/en/about/about-the-hutch/diversity-equity-inclusion.html", "/en/about/about-the-hutch/health-equity.html", "/en/about/about-the-hutch/history.html", "/en/about/about-the-hutch/honors-awards.html", "/en/about/about-the-hutch/institutional-partners-collaborations.html", "/en/about/about-the-hutch/leadership.html", "/en/about/about-the-hutch/mission-values.html", "/en/about/contact-us.html", "/en/about/contact-us.html", "/en/about/contact-us/campus-map.html", "/en/about/contact-us/virtual-visit.html", "/en/about/contact-us/transportation.html", "/en/about/fred-hutch-locations.html", "/en/about/careers.html", "/en/events.html", "/en/about/for-media.html", "/en/news.html", "#0", "/en/ways-to-give.html", "/en/ways-to-give/give-now.html", "/en/ways-to-give/honor-a-loved-one.html", "/en/ways-to-give/give-through-your-will.html", "/en/ways-to-give/give-through-your-donor-advised-fund.html", "/en/ways-to-give/donate-cryptocurrency.html", "/en/ways-to-give/give-through-your-foundation.html", "/en/ways-to-give/make-a-corporate-gift.html", "/en/ways-to-give/create-an-endowment.html", "/en/ways-to-give/fundraise-for-fred-hutch.html", "/en/ways-to-give/fundraise-for-fred-hutch.html", "https://www.obliteride.org", "/en/ways-to-give/fundraise-for-fred-hutch/create-your-own.html", "/en/ways-to-give/fundraise-for-fred-hutch/fundraiser-login.html", "/en/ways-to-give/philanthropy-events.html", "/en/ways-to-give/support-our-science.html", "/en/ways-to-give/support-our-science.html", "/en/ways-to-give/support-our-science/greatest-need.html", "/en/ways-to-give/support-our-science/cancer-research.html", "/en/ways-to-give/support-our-science/data-science.html", "/en/ways-to-give/support-our-science/diversity-and-health-equity.html", "/en/ways-to-give/support-our-science/immunotherapy.html", "/en/ways-to-give/support-our-science/patient-support-services.html", "/en/ways-to-give/support-our-science/precision-oncology.html", "/en/ways-to-give/support-our-science/viruses-vaccines-infectious-diseases.html", "/en/ways-to-give/gift-clubs.html", "/en/ways-to-give/other-ways-to-give.html", "/en/ways-to-give/other-ways-to-give.html", "/en/ways-to-give/other-ways-to-give/give-monthly.html", "/en/ways-to-give/other-ways-to-give/donate-stock-bonds-mutual-funds.html", "/en/ways-to-give/other-ways-to-give/give-at-work.html", "/en/ways-to-give/other-ways-to-give/donate-vehicle-or-real-estate.html", "/en/ways-to-give/contact-us.html", "/en/patient-care/my-chart.html", "/en/patient-care/request-appointment.html", "/en/provider-directory.html", "/en/patient-care/for-physicians.html", "/en/about/careers.html", "/en/about/fred-hutch-locations.html", "/en/about/contact-us.html", "/en/util/redirect_stubs/donate.html", "/en/news/spotlight.html", "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html&title=Un+ensayo+cl%C3%ADnico+inicial+destaca+las+vacunas+contra+el+c%C3%A1ncer+como+posible+tratamiento+asequible%2C+seguro+y+eficaz+contra+el+c%C3%A1ncer+de+mama&summary=La+vacuna+de+ADN+para+el+c%C3%A1ncer+de+mama+mejora+la+supervivencia+de+las+pacientes+con+c%C3%A1ncer+de+mama+HER2+positivo+en+estadio+tard%C3%ADo+en+un+ensayo+cl%C3%ADnico+no+aleatorizado+de+fase+I.&source=Fred+Hutch", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html&via=fredhutch", "mailto:?subject=www.fredhutch.orgUn%20ensayo%20cl%C3%ADnico%20inicial%20destaca%20las%20vacunas%20contra%20el%20c%C3%A1ncer%20como%20posible%20tratamiento%20asequible%2C%20seguro%20y%20eficaz%20contra%20el%20c%C3%A1ncer%20de%20mama&body=From%20Fred%20Hutchinson%20Cancer%20Center%3A%0A%0AUn%20ensayo%20cl%C3%ADnico%20inicial%20destaca%20las%20vacunas%20contra%20el%20c%C3%A1ncer%20como%20posible%20tratamiento%20asequible%2C%20seguro%20y%20eficaz%20contra%20el%20c%C3%A1ncer%20de%20mama%0A%0ADel%20Cancer%20Vaccine%20Institute%20%5BInstituto%20de%20Vacunas%20contra%20el%20C%C3%A1ncer%5D%2C%20la%20Universidad%20de%20Washington%20y%20del%20Cancer%20Consortium%20Breast%20%26%20Ovary%20Cancers%20Program%20%5BPrograma%20de%20C%C3%A1ncer%20de%20Mama%20y%20Ovario%20del%20Consorcio%20del%20C%C3%A1ncer%5D.%0A%0Ahttps%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html%0A%0Awww.fredhutch.org", "https://www.fredhutch.org/en/news/spotlight/2023/07/ccsg-disis-jamaoncology.html", "https://www.uwcvi.org/", "https://www.cancerconsortium.org/about/research-programs.html", "https://jamanetwork.com/journals/jamaoncology/article-abstract/2797975", "https://www.uwcvi.org/team/mary-%28nora%29-disis%2C-md", "https://www.fredhutch.org/en/faculty-lab-directory/disis-nora-mary.html", "https://www.uwcvi.org/team/kiran-dhillon%2C-phd", "https://www.fredhutch.org/en/faculty-lab-directory/guthrie-katherine.html", "http://astonsci.com/", "https://www.uwcvi.org/clinical-trial-opportunities", "https://www.uwcvi.org/immunology-101-faq", "https://pubmed.ncbi.nlm.nih.gov/36326756/", "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html&title=Un+ensayo+cl%C3%ADnico+inicial+destaca+las+vacunas+contra+el+c%C3%A1ncer+como+posible+tratamiento+asequible%2C+seguro+y+eficaz+contra+el+c%C3%A1ncer+de+mama&summary=La+vacuna+de+ADN+para+el+c%C3%A1ncer+de+mama+mejora+la+supervivencia+de+las+pacientes+con+c%C3%A1ncer+de+mama+HER2+positivo+en+estadio+tard%C3%ADo+en+un+ensayo+cl%C3%ADnico+no+aleatorizado+de+fase+I.&source=Fred+Hutch", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html&via=fredhutch", "mailto:?subject=www.fredhutch.orgUn%20ensayo%20cl%C3%ADnico%20inicial%20destaca%20las%20vacunas%20contra%20el%20c%C3%A1ncer%20como%20posible%20tratamiento%20asequible%2C%20seguro%20y%20eficaz%20contra%20el%20c%C3%A1ncer%20de%20mama&body=From%20Fred%20Hutchinson%20Cancer%20Center%3A%0A%0AUn%20ensayo%20cl%C3%ADnico%20inicial%20destaca%20las%20vacunas%20contra%20el%20c%C3%A1ncer%20como%20posible%20tratamiento%20asequible%2C%20seguro%20y%20eficaz%20contra%20el%20c%C3%A1ncer%20de%20mama%0A%0ADel%20Cancer%20Vaccine%20Institute%20%5BInstituto%20de%20Vacunas%20contra%20el%20C%C3%A1ncer%5D%2C%20la%20Universidad%20de%20Washington%20y%20del%20Cancer%20Consortium%20Breast%20%26%20Ovary%20Cancers%20Program%20%5BPrograma%20de%20C%C3%A1ncer%20de%20Mama%20y%20Ovario%20del%20Consorcio%20del%20C%C3%A1ncer%5D.%0A%0Ahttps%3A%2F%2Fwww.fredhutch.org%2Fcontent%2Fwww%2Fen%2Fnews%2Fspotlight%2F2023%2F07%2Fccsg-disis-jamaoncology-spanish.html%0A%0Awww.fredhutch.org", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0IvYnJlYXN0IGNhbmNlcidd.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL1YvdmFjY2luZSdd.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0QvZG5hLXZhY2NpbmVzJ10=.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0MvY2xpbmljYWwtdHJpYWxzJ10=.html", "/en/news.related.Wyd3ZWItZmFjdWx0eTpEL05vcmEgRGlzaXMnXQ==.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0IvYnJlYXN0LWNhbmNlci10cmVhdG1lbnQnXQ==.html", "/en/news.related.Wyd3ZWItZXRjOmtleXdvcmRzL0MvY2FuY2VyLXZhY2NpbmUnXQ==.html", "/en/about/for-media.html", "/en/news/releases.html", "/en/news/media-coverage.html", "/en/about/about-the-hutch.html", "/en.html", "/en/about/contact-us.html", "/en/about/about-the-hutch/accountability-impact.html", "/en/about/contact-us/employee.html", "http://engage.fredhutch.org/site/Survey?SURVEY_ID=1360&ACTION_REQUIRED=URI_ACTION_USER_REQUESTS", "/en/util/terms-privacy.html", "/en/util/conflict-of-interest.html", "/en/util/patient-policies.html#public-policy", "/en/util/patient-policies.html#public-care-policy", "/en/util/patient-policies.html#disclaimer", "/en/util/patient-policies.html#notice-nondiscrimination-accessibility-a", "https://www.facebook.com/HutchinsonCenter", "https://twitter.com/fredhutch", "https://www.linkedin.com/company/fred-hutchinson-cancer-research-center/", "https://www.youtube.com/channel/UCnWBh22UKMHF4VRKdsQvZqg/featured", "https://www.instagram.com/FredHutch/", "tel:206-667-5000", "/en/about/contact-us.html", "https://www.cancer.gov", "https://www.nccn.org", "http://www.aahrpp.org", "https://www.forbes.com/best-midsize-employers/list/", "https://www.guidestar.org/profile/shared/4a568da4-8981-4bd6-b3fe-86c28f77f341", "https://www.eeoc.gov/sites/default/files/2022-10/EEOC_KnowYourRights_screen_reader_10_20.pdf", "#top"]}